Receptor Protein-Tyrosine Kinases
Recent studies by Q. Wei and co-authors add new data to receptor protein-tyrosine kinases findings
Published in Drug Week, January 14th, 2011
2011 JAN 14 -- Current study results from the report, 'EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy,' have been published. "Members of the epidermal growth factor receptor, EGFR, family are interesting as targets for radionuclide therapy using targeting agents labeled with a-or ß-emitting radionuclides, especially when EGFR-positive colorectal carcinomas, CRC, are resistant to EGFR inhibiting agents like cetuximab and various tyrosine kinase inhibitors. The expression of EGFR, HER2 and HER3 was therefore analyzed in CRC samples from primary tumors, corresponding lymph node...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-01-14)
More Articles from Drug Week
- Drug Development
Akita University reports research in drug development - Drug Development
Data from China Pharmaceutical University advance knowledge in drug development - Biological and Pharmaceutical Research
Data from University Federal do Ceara advance knowledge in biological and pharmaceutical research - Cancer Therapy
Data on cancer therapy reported by C.A. Goard and co-researchers - Clinical Trials Research
Data on clinical trials research described by researchers at Aarhus University Hospital Skejby - Drug Development
Data on drug development published by C.V. Pastuskovas and colleagues - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
